M. Ratcliffe

2.5k citations

47 papers · 1.6k indexed · h-index 20

Impact in

Cancer Research top 5%
- Cancer Genomics and Diagnostics
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies

Papers in ⓘ

Oncology 22
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 5
- Pancreatic and Hepatic Oncology Research 4
Cancer Research 12
- Cancer Genomics and Diagnostics 12

Co-authors: Sergei Y. Sokol (3 shared papers)Keiji Itoh (3 shared papers)Jill Walker (17 shared papers)Craig Barker (13 shared papers)Marietta Scott (14 shared papers)Nicola Normanno (7 shared papers)Martin Reck (5 shared papers)Paul Scorer (10 shared papers)
Journals: Annals of Oncology (6 papers)Journal of Thoracic Oncology (5 papers)Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

M. Ratcliffe

44 papers receiving 1.6k citations

Peers

Countries citing papers authored by M. Ratcliffe

Since Specialization

Citations

This map shows the geographic impact of M. Ratcliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ratcliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ratcliffe more than expected).

Fields of papers citing papers by M. Ratcliffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ratcliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ratcliffe. The network helps show where M. Ratcliffe may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Ratcliffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Ratcliffe Line = papers co-authored together M. Ratcliffe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer Clinical Cancer Research ·M. Ratcliffe, Alan Sharpe, Anita Midha, Craig Barker, Marietta Scott, Paul Scorer, Hytham Al‐Masri, Marlon C. Rebelatto, Jill Walker	2017	237
2	Nuclear localization is required for Dishevelled function in Wnt/β-catenin signaling Journal of Biology ·Keiji Itoh, Barbara K. Brott, Gyu‐Un Bae, M. Ratcliffe, Sergei Y. Sokol	2005	186
3	ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study Journal of Thoracic Oncology ·Martin Reck, Koichi Hagiwara, Baohui Han, Sergei Tjulandin, Christian Grohé, Takashi Yokoi, Alessandro Morabito, Silvia Novello, Edurne Arriola, Olivier Molinier, Rose McCormack, M. Ratcliffe, Nicola Normanno	2016	131
4	EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study Lung Cancer ·Baohui Han, Sergei Tjulandin, Koichi Hagiwara, Nicola Normanno, Laksmi Wulandari, К. К. Лактионов, Achmad Hudoyo, Yong He, Yiping Zhang, Meng-Zhao Wang, Chien Ying Liu, M. Ratcliffe, Rose McCormack, Martin Reck	2017	113
5	Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer Oncotarget ·Nicola Normanno, Marc G. Denis, Kenneth S. Thress, M. Ratcliffe, Martin Reck	2016	103
6	A Positive Role for the PP2A Catalytic Subunit in Wnt Signal Transduction Journal of Biological Chemistry ·M. Ratcliffe, Keiji Itoh, Sergei Y. Sokol	2000	89
7	Interaction of Dishevelled and Xenopus Axin-Related Protein Is Required for Wnt Signal Transduction Molecular and Cellular Biology ·Keiji Itoh, Alena A Antipova, M. Ratcliffe, Sergei Y. Sokol	2000	83
8	Dephosphorylation of the catenins p120 and p100 in endothelial cells in response to inflammatory stimuli Biochemical Journal ·M. Ratcliffe, Caroline Smales, James M. Staddon	1999	58
9	CpG-containing immunostimulatory DNA sequences elicit TNF-α–dependent toxicity in rodents but not in humans Journal of Clinical Investigation ·John D. Campbell, Yan Cho, Martyn Foster, Holger Kanzler, Melissa A. Kachura, Jeremy A. Lum, M. Ratcliffe, Atul Sathe, Andrew J. Leishman, Ash Bahl, Mark McHale, Robert L. Coffman, Edith M. Hessel	2009	57
10	Activation of E-prostanoid₄and E-prostanoid₂receptors inhibits TNF-α release from human alveolar macrophages European Respiratory Journal ·M. Ratcliffe, Andrew Walding, Philip A. Shelton, Alice W. Flaherty, Iain G. Dougall	2007	51
11	Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review Journal of Experimental & Clinical Cancer Research ·James Sherwood, Simon Dearden, M. Ratcliffe, Jill Walker	2015	49
12	Dephosphorylation of the Cadherin-associated p100/p120 Proteins in Response to Activation of Protein Kinase C in Epithelial Cells Journal of Biological Chemistry ·M. Ratcliffe, Lee L. Rubin, James M. Staddon	1997	45
13	Cytology for PD-L1 testing: A systematic review Lung Cancer ·John R. Gosney, Anne-Marie Boothman, M. Ratcliffe, Keith M. Kerr	2020	42
14	Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma Diagnostic Pathology ·M Zając, Marietta Scott, M. Ratcliffe, Paul Scorer, Craig Barker, Hytham Al‐Masri, Marlon C. Rebelatto, Jill Walker	2019	38
15	Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study Journal of Thoracic Oncology ·Anne-Marie Boothman, Marietta Scott, M. Ratcliffe, Jessica Whiteley, Phillip A. Dennis, Catherine Wadsworth, Alan Sharpe, Naiyer A. Rizvi, Marina Chiara Garassino, Jill Walker	2019	33
16	Determining the Prevalence of EGFR Mutations in Asian and Russian Patients (PTS) with Advanced Non-Small-Cell Lung Cancer (ANSCLC) of Adenocarcinoma (ADC) and Non-Adc Histology: Ignite Study Annals of Oncology ·Baohui Han, Sergei Tjulandin, Koichi Hagiwara, Nicola Normanno, Laksmi Wulandari, Лактионов Константин Константинович, Achmad Hudoyo, M. Ratcliffe, R. McCormack, Martin Reck	2015	28
17	Differential gene expression analysis in human monocyte-derived macrophages: Impact of cigarette smoke on host defence Molecular Immunology ·Ian Doyle, M. Ratcliffe, Andrew Walding, Elizabeth Vanden Bon, Michael Dymond, Wendy Tomlinson, D. R. Tilley, Philip A. Shelton, Iain G. Dougall	2009	28
18	Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists Bioorganic & Medicinal Chemistry Letters ·Christopher A. Luckhurst, Linda Stein, Mark Furber, N.A. Webb, M. Ratcliffe, Gary Allenby, Sara Botterell, Wendy Tomlinson, Barrie Martin, Andrew Walding	2010	25
19	Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay Diagnostic Pathology ·Paul Scorer, Marietta Scott, Nicola Lawson, M. Ratcliffe, Craig Barker, Marlon C. Rebelatto, Jill Walker	2018	22
20	Prostaglandin D2 Regulates CD4+ Memory T Cell Trafficking across Blood Vascular Endothelium and Primes These Cells for Clearance across Lymphatic Endothelium The Journal of Immunology ·Syed Rumel Ahmed, Helen M. McGettrick, Clara M. Yates, Christopher D. Buckley, M. Ratcliffe, Gerard B. Nash, G. Ed Rainger	2011	21

About M. Ratcliffe

M. Ratcliffe is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Statistics and Probability, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (12 papers), Lung Cancer Diagnosis and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers), CAR-T cell therapy research (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (411 citations), Oncology (680 citations), Pulmonary and Respiratory Medicine (661 citations), Immunology (198 citations) and Molecular Biology (619 citations). M. Ratcliffe has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Sergei Y. Sokol, Keiji Itoh, Jill Walker, Craig Barker, Marietta Scott, Nicola Normanno, Martin Reck, Paul Scorer, Marlon C. Rebelatto and James M. Staddon. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Cancer Research, Journal of Clinical Oncology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact